secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dogwood Therapeutics, Inc. (DWTX)
CIK:        0001818844
Form:       8-K
Filed at:   2023-07-17T23:59:59+00:00
Accession:  0001558370-23-011904
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Virios announces positive Long-COVID data for valacyclovir/celecoxib; cash $4.5M
--------------------------------------------------------------------------------

- Female long-COVID patients showed significant improvements in fatigue, pain, and autonomic dysfunction after 14 weeks of Val/Cel vs routine care.
- Company plans to meet with FDA in H2 2023 to discuss opening an IND for formal PASC treatment assessment.
- Treatment well tolerated; no serious adverse events; nausea most common AE in Val/Cel group.
- As of June 30, 2023, Virios had approximately $4.5M in cash and cash equivalents.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818844/000155837023011904/0001558370-23-011904-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818844/000155837023011904/tmb-20230714x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-011904

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer